Koumine inhibits IL-1β-induced chondrocyte inflammation and ameliorates extracellular matrix degradation in osteoarthritic cartilage through activation of PINK1/Parkin-mediated mitochondrial autophagy

Biomed Pharmacother. 2024 Apr:173:116273. doi: 10.1016/j.biopha.2024.116273. Epub 2024 Feb 26.

Abstract

Osteoarthritis (OA) is a degenerative joint disease, Increasingly, mitochondrial autophagy has been found to play an important regulatory role in the prevention and treatment of osteoarthritis. Koumine is a bioactive alkaloid extracted from the plant Gelsemium elegans. In previous research, Koumine was found to have potential in improving the progression of OA in rats. However, the specific mechanism of its action has not been fully explained. Therefore, the aim of this study was to investigate whether Koumine can alleviate OA in rats by influencing mitochondrial autophagy. In the in vitro study, rat chondrocytes (RCCS-1) were induced with IL-1β (10 ng/mL) to induce inflammation, and Koumine (50 μg/mL) was co-treated. In the in vivo study, a rat OA model was established by intra-articular injection of 2% papain, and Koumine was administered orally (1 mg/kg, once daily for two weeks). It was found that Koumine effectively reduced cartilage erosion in rats with osteoarthritis. Additionally, it decreased the levels of inflammatory factors such as IL-1β, IL-6, and extracellular matrix (ECM) components MMP13 and ADAMTS5 in chondrocytes and articular cartilage tissue, while increasing the level of Collagen II.Koumine inhibited the production of reactive oxygen species (ROS) in cartilage tissue and increased the number of autophagosomes in chondrocytes and articular cartilage tissue. Additionally, it upregulated the expression of mitochondrial autophagy proteins LC3Ⅱ/Ⅰ, PINK1, Parkin, and Drp1. The administration of Mdivi-1 (50 μM) reversed the enhanced effect of Koumine on mitochondrial autophagy, as well as its anti-inflammatory and anti-ECM degradation effects in rats with OA. These findings suggest that Koumine can alleviate chondrocyte inflammation and improve the progression of OA in rats by activating PINK1/Parkin-mediated mitochondrial autophagy.

Keywords: Extracellular matrix; IL-1β (PubChem CID 123872); Koumine; Koumine (PubChem CID 102004413); Meloxicam (PubChem CID 54677470); Mitophagy; Osteoarthritis; PINK1/Parkin.

MeSH terms

  • Animals
  • Autophagy
  • Cartilage, Articular* / metabolism
  • Chondrocytes / metabolism
  • Extracellular Matrix / metabolism
  • Indole Alkaloids*
  • Inflammation / drug therapy
  • Inflammation / metabolism
  • Interleukin-1beta / metabolism
  • Osteoarthritis* / drug therapy
  • Osteoarthritis* / metabolism
  • Protein Kinases / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Ubiquitin-Protein Ligases / metabolism

Substances

  • koumine
  • Interleukin-1beta
  • Ubiquitin-Protein Ligases
  • Protein Kinases
  • Indole Alkaloids